Julia Tillmanns



close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Cyclin-Dependent Kinase 8 Represents a Positive Regulator of Cytomegalovirus Replication and a Novel Host Target for Antiviral Strategies (2024) Obergfäll D, Wild M, Sommerer M, Barillas Dahm M, Kicuntod J, Tillmanns J, Kögler M, et al. Journal article Establishment of a Luciferase-Based Reporter System to Study Aspects of Human Cytomegalovirus Infection, Replication Characteristics, and Antiviral Drug Efficacy (2024) Tillmanns J, Kicuntod J, Ehring A, Elbasani E, Borst EM, Obergfäll D, Müller R, et al. Journal article Discovery of a Novel Antiviral Effect of the Restriction Factor SPOC1 against Human Cytomegalovirus (2024) Kuderna AK, Reichel A, Tillmanns J, Class M, Scherer M, Stamminger T Journal article ‘Getting Better’—Is It a Feasible Strategy of Broad Pan-Antiherpesviral Drug Targeting by Using the Nuclear Egress-Directed Mechanism? (2024) Tillmanns J, Kicuntod J, Lösing J, Marschall M Journal article, Review article An Antiherpesviral Host-Directed Strategy Based on CDK7 Covalently Binding Drugs: Target-Selective, Picomolar-Dose, Cross-Virus Reactivity (2024) Yu DH, Wagner S, Schütz M, Jeon Y, Seo M, Kim J, Brückner N, et al. Journal article Validation of nuclear receptor RORγ isoform 1 as a novel host-directed antiviral target based on the modulation of cholesterol levels (2024) Wangen C, Raithel A, Tillmanns J, Gege C, Herrmann A, Vitt D, Kohlhof H, et al. Journal article Assessment of Covalently Binding Warhead Compounds in the Validation of the Cytomegalovirus Nuclear Egress Complex as an Antiviral Target (2023) Tillmanns J, Häge S, Borst EM, Wardin J, Eickhoff J, Klebl B, Wagner S, et al. Journal article